User profiles for Hanna Nohynek
Hanna NohynekVerified email at thl.fi Cited by 3056 |
[HTML][HTML] AS03 adjuvanted AH1N1 vaccine associated with an abrupt increase in the incidence of childhood narcolepsy in Finland
Background Narcolepsy is a chronic sleep disorder with strong genetic predisposition causing
excessive daytime sleepiness and cataplexy. A sudden increase in childhood narcolepsy …
excessive daytime sleepiness and cataplexy. A sudden increase in childhood narcolepsy …
SARS-CoV-2 vaccination and myocarditis in a Nordic cohort study of 23 million residents
…, N Pihlström, JV Hansen, H Nohynek… - JAMA …, 2022 - jamanetwork.com
Importance Reports of myocarditis after SARS-CoV-2 messenger RNA (mRNA) vaccination
have emerged. Objective To evaluate the risks of myocarditis and pericarditis following SARS…
have emerged. Objective To evaluate the risks of myocarditis and pericarditis following SARS…
Report from a WHO Working Group: standard method for detecting upper respiratory carriage of Streptococcus pneumoniae
KL O'brien, H Nohynek… - The Pediatric …, 2003 - journals.lww.com
Background. Numerousstudies evaluating the efficacy of conjugate pneumococcal vaccines
are being conducted or planned throughout the world. Some of these studies are evaluating …
are being conducted or planned throughout the world. Some of these studies are evaluating …
[HTML][HTML] Standard method for detecting upper respiratory carriage of Streptococcus pneumoniae: updated recommendations from the World Health Organization …
In 2003 the World Health Organization (WHO) convened a working group and published a
set of standard methods for studies measuring nasopharyngeal carriage of Streptococcus …
set of standard methods for studies measuring nasopharyngeal carriage of Streptococcus …
Pneumococcal conjugate vaccines for preventing vaccine‐type invasive pneumococcal disease and X‐ray defined pneumonia in children less than two years of age
…, G Williams, RAN Parreño, H Nohynek… - Cochrane database …, 2009 - cochranelibrary.com
Background Pneumonia, caused by Streptococcus pneumoniae, is a major cause of
morbidity and mortality among children in low‐income countries. The effectiveness of …
morbidity and mortality among children in low‐income countries. The effectiveness of …
[HTML][HTML] Global burden of respiratory infections associated with seasonal influenza in children under 5 years in 2018: a systematic review and modelling study
…, LT Nillos, SP Lupisan, H Nohynek… - The Lancet Global …, 2020 - thelancet.com
Background Seasonal influenza virus is a common cause of acute lower respiratory
infection (ALRI) in young children. In 2008, we estimated that 20 million influenza-virus-associated …
infection (ALRI) in young children. In 2008, we estimated that 20 million influenza-virus-associated …
Antibodies to influenza nucleoprotein cross-react with human hypocretin receptor 2
The sleep disorder narcolepsy is linked to the HLA-DQB1*0602 haplotype and dysregulation
of the hypocretin ligand-hypocretin receptor pathway. Narcolepsy was associated with …
of the hypocretin ligand-hypocretin receptor pathway. Narcolepsy was associated with …
Safety of immunization during pregnancy: a review of the evidence of selected inactivated and live attenuated vaccines
Vaccine-preventable infectious diseases are responsible for significant maternal, neonatal,
and young infant morbidity and mortality. While there is emerging scientific evidence, as well …
and young infant morbidity and mortality. While there is emerging scientific evidence, as well …
[HTML][HTML] Learning about COVID-19-related stigma, quarantine and isolation experiences in Finland
Background The COVID-19 pandemic has intensely changed the everyday lives of people
worldwide. This study explores the forms and outcomes of coronavirus and COVID-19-related …
worldwide. This study explores the forms and outcomes of coronavirus and COVID-19-related …
[HTML][HTML] COVID-19 vaccine strategies must focus on severe disease and global equity
…, E Mohsni, K Mulholland, KM Neuzil, H Nohynek… - The Lancet, 2022 - thelancet.com
In September, 2020, the WHO Prioritisation Roadmap for COVID-19 vaccines gave priority
to prevention of severe disease and the highest risk groups. In July, 2021, the revised …
to prevention of severe disease and the highest risk groups. In July, 2021, the revised …